Table 2. Observed and disease-specific 5-year survival after endometrial cancer according to stage.
n | Number of endometrial cancer deaths | Median follow-up (days) | Overall 5-year survivala (%) | Disease specific 5-year survivalb (%) | |
---|---|---|---|---|---|
Stage I | 112 | 14 | 1825 | 85 | 88 |
Stage II | 14 | 8 | 1176 | 36 | 43 |
Stage III cyt | 17 | 1 | 1825 | 94 | 94 |
Stage IIIA hist | 18 | 8 | 1048 | 44 | 51 |
Stage IIIB + | 9 | 5 | 1224 | 44 | 44 |
Stage I=tumour confined to uterus; stage II=tumour invading cervix; stage IIIA cyt=positive peritoneal cytology; Stage IIIA hist=histological involvement of serosa or adnexa; stage IIIB+=tumour invading vagina, mucosa of bladder/bowel, regional lymph node or distant metastases.
All cases of death.
Death from endometrial cancer.